Flow Cytometer Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2023-2027

Published: Apr 2024 Pages: 169 SKU: IRTNTR46387

Flow Cytometry Market Forecast 2023-2027 

The flow cytometry market size is projected to increase by USD 6.04 billion at a CAGR of 13.12% between 2022 and 2027. Market growth is influenced by several factors, notably the escalating expenditure on research and development (R&D), which drives innovation and technological advancements in flow cytometry. The expanding array of applications for flow cytometers across various sectors, including healthcare, biotechnology, and research, contributes significantly to market expansion. Furthermore, continuous technological advances in flow cytometry systems enhance their efficiency and capabilities, catering to evolving user requirements. These factors collectively foster a conducive environment for market growth, emphasizing the importance of R&D investment and technological innovation in driving the market forward.

Moreover, the market growth and forecasting report includes key player's detailed analyses of the competitive landscape of the market and information about 20 market companies, including Abbott Laboratories, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. Additionally, Amphasys AG company offers flow cytometry such as Ampha X30.

What will be the Size of the Market During the Forecast Period?

For More Highlights About this Report, Download Free Sample in a Minute 

Market Dynamics 

The market is characterized by its ability to analyze multiparametric data in stem cell cultures using fluorescent-labeled antibodies and compounds. It aids in understanding stem cell behavior and control parameters, essential for biopharmaceutical research activities and diagnosing autoimmune disorders like AIDS. With advanced flow cytometer instruments and microfluidic flow cytometry, it offers precise analysis, complementing techniques such as Western blotting, immunohistochemistry, and microscopy in data analysis solutions. Further, flow cytometry-based cell sorters, coupled with fluorescent-labeled compounds, facilitate the operator's analytical process flow, offering precise and efficient cell sorting capabilities essential for various flow cytometry services and techniques involving the analysis and characterization of cells using specialized instruments. Our researchers analyzed the market research and growth data with 2022  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Market  Driver

Increasing R&D investment emerges as a pivotal driver for the global market's expansion. Over the past decade, global R&D spending has shown a consistent upward trajectory. The rise in the occurrence of various ailments like Cancer, HIV/AIDS, and COVID-19, alongside conditions such as Immunodeficiency disorders and Infectious diseases, fuels the urgency to develop effective treatments such as PCR
Antibody-based testing, prompting heightened investment in the Biotechnology and Life science sectors.

Further, pharmaceutical entities prioritize R&D endeavors to enrich their product pipelines, catering to diverse therapeutic needs. A surge in R&D outlays is witnessed as companies strive to innovate and introduce novel drugs. The escalating demand for cutting-edge technologies underscores the significance of this market segment's growth in the foreseeable future.

Significant Market Trends

The increasing level of process automation is the primary trend shaping the market growth. Automation is evident in nearly all laboratory processes, including flow cytometry. From using manual sample preparation and loading techniques earlier to now using instruments that are designed to prepare, load, and store samples for the process, the technology and level of automation have improved greatly over the past couple of decades. As these devices have digital interfaces and allow the storage of processed information, they reduce the human intervention required substantially.

Further, the integration of these instruments with other devices and processes can increase flexibility, allow continuous process flow for the samples, and reduce processing time and human supervision. Additionally, most instruments and devices used in a modern laboratory can be integrated into a digital ecosystem to enable seamless integration from one process to the next. This will allow for greater throughput, better accuracy, energy efficiency, reduced wastage of resources, and lower operating costs in the long run. Therefore, the global market is expected to witness high growth during the forecast period.

Major Market Restrain

The inefficient distribution network is the major challenge that affects the market expansion. Most of the major manufacturers of flow cytometers are either American or German. On average, these vendors have manufacturing or sales units in 3-5 countries worldwide, which means that the countries that do not have a manufacturing or sales unit of these vendors will have to import the instrument from the closest country that does.

Thus, coupled with the complexities involved in the logistics of these instruments, leads to an inefficient distribution network. However, the introduction of e-commerce, and safe third-party logistics, are gradually helping manufacturers to overcome this hurdle. This will negatively impact the growth of the market during the forecast period.

Market Segmentation 

By Product 

The market share growth by the reagents and consumables segment will be significant during the forecast period. This product segment generated high sales revenue due to the significantly higher volume of sales and the short product replacement or replenishment cycle. The primary functions of these reagents and consumables include Cell separation, Cell detection, Blocking, Cell status analysis, Performance control, and Cell staining. Such factors will increase segment growth during the forecast period.

Get a glance at the market contribution of various segments Download the PDF Sample

The reagents and consumables segment was valued at USD 2.54 billion in 2017. The reagents or markers used to detect molecules and other proteins in cells through various methods usually have a life of one process and cannot be reused as they are absorbed into the cell body. This necessitates the use of new reagents and markers for a subsequent process. The rising number of diagnostic processes in healthcare facilities worldwide has led to a rise in demand for flow cytometry reagents, particularly in the detection of conditions such as cancer and HIV. 

By End-User

 The pharmaceutical industry?segment will account for the largest share of this segment.? The pharmaceutical sector is experiencing rapid expansion worldwide, with a significant focus on developing personalized medicine, presenting lucrative opportunities for drug companies. This trend drives demand for advanced analytical tools like flow cytometers and consumables, facilitating pharmacodynamics, molecular, and genomic analyses, as well as drug delivery studies. Factors such as the presence of global and regional pharmaceutical firms, heightened R&D investments, and increasing demand for innovative technologies propel growth in the market within the pharmaceutical industry.

 

Regional Overview

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. 
Technavio's analysts have provided extensive insight into the market forecast, detailing the regional trends and drivers influencing the market's trajectory throughout the forecast period. The North American market is driven by factors like increasing disease prevalence, pharmaceutical company presence, drug development endeavors, and technology adoption. Outsourcing R&D to contract research organizations (CROs), rising healthcare spending, and a robust market players landscape further contribute to market growth. The region witnesses a surge in chronic and infectious diseases, prompting extensive research and drug development, thus boosting demand for advanced analytical tools like flow cytometers. Additionally, prominent pharmaceutical firms' focus on new drug molecules fuels market expansion by driving instrument demand.

Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and trends strategies.

Global Market Customer Landscape

Market Companies

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

  • Agilent Technologies Inc. offers flow cytometry such as NovoCyte Advanteon, NovoCyte Penteon, and NovoCyte Quanteon.

Market analysis and report of qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market research report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017-2027

  • Product Outlook
    • Reagents and consumables
    • Instruments
    • Others
  • Application Outlook
    • Pharmaceutical industry
    • Health and diagnostic centers
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Australia
      • Brazil

 Market Analyst Overview:

The market is experiencing significant advancements driven by hospitals, clinical testing laboratories, and contract research organizations (CROs). With a focus on drug discovery services and cellular diagnostics, innovators are leveraging flow cytometry techniques to analyze immune cells for conditions like leukemia and lymphoma. Companies like FlowMetric Life Sciences and Flow Contract Sites Laboratory offer flow cytometry analysis services utilizing flow cytometry instruments and liquid handling robotics. These technologies enable precise fluorochrome combinations and cell-based flow cytometry, enhancing drug development activities and aiding in the diagnosis of diseases such as tuberculosis and sexually transmitted diseases.

Further, the market encompasses a wide array of offerings, including software, reagents & consumables, and accessories essential for precise analysis. Innovations in flow cytometry technique by industry leaders and contract service providers are driving advancements in cell line development and flow cytometric services. With the integration of digital signal processing and point-of-care diagnostics, flow cytometry enables rapid and accurate analysis. Additionally, bead-based assays are gaining prominence in clinical testing labs, offering versatile solutions for various research and diagnostic applications. These developments highlight the evolving landscape of flow cytometry and its pivotal role in biomedical research and healthcare.

Market Scope

Report Coverage

Details

Page number

169

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 13.12%

Market growth 2023-2027

USD 6.04 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

12.09

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market report forecast during the forecast period
  • Detailed information on factors that will drive the growth of the market  between 2023 and 2027
  • Precise estimation of the market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough market analysis and report of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of Industry companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global flow cytometry market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global flow cytometry market 2017 - 2021 ($ billion)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Reagents and consumables - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
    • 6.4 Instruments - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Product
      • Exhibit 46: Market opportunity by Product ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 50: Chart on Comparison by End-user
      • Exhibit 51: Data Table on Comparison by End-user
    • 7.3 Pharmaceutical industry - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 54: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
    • 7.4 Health and diagnostic centers - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Health and diagnostic centers - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Data Table on Health and diagnostic centers - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 58: Chart on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ billion)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 115: Agilent Technologies Inc. - Overview
              • Exhibit 116: Agilent Technologies Inc. - Business segments
              • Exhibit 117: Agilent Technologies Inc. - Key news
              • Exhibit 118: Agilent Technologies Inc. - Key offerings
              • Exhibit 119: Agilent Technologies Inc. - Segment focus
            • 12.4 Amphasys AG
              • Exhibit 120: Amphasys AG - Overview
              • Exhibit 121: Amphasys AG - Product / Service
              • Exhibit 122: Amphasys AG - Key offerings
            • 12.5 Apogee Flow Systems Ltd.
              • Exhibit 123: Apogee Flow Systems Ltd. - Overview
              • Exhibit 124: Apogee Flow Systems Ltd. - Product / Service
              • Exhibit 125: Apogee Flow Systems Ltd. - Key offerings
            • 12.6 Becton Dickinson and Co.
              • Exhibit 126: Becton Dickinson and Co. - Overview
              • Exhibit 127: Becton Dickinson and Co. - Business segments
              • Exhibit 128: Becton Dickinson and Co. - Key news
              • Exhibit 129: Becton Dickinson and Co. - Key offerings
              • Exhibit 130: Becton Dickinson and Co. - Segment focus
            • 12.7 Bio Rad Laboratories Inc.
              • Exhibit 131: Bio Rad Laboratories Inc. - Overview
              • Exhibit 132: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 133: Bio Rad Laboratories Inc. - Key news
              • Exhibit 134: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 135: Bio Rad Laboratories Inc. - Segment focus
            • 12.8 Cytek Biosciences Inc.
              • Exhibit 136: Cytek Biosciences Inc. - Overview
              • Exhibit 137: Cytek Biosciences Inc. - Product / Service
              • Exhibit 138: Cytek Biosciences Inc. - Key offerings
            • 12.9 Danaher Corp.
              • Exhibit 139: Danaher Corp. - Overview
              • Exhibit 140: Danaher Corp. - Business segments
              • Exhibit 141: Danaher Corp. - Key news
              • Exhibit 142: Danaher Corp. - Key offerings
              • Exhibit 143: Danaher Corp. - Segment focus
            • 12.10 DiaSorin SpA
              • Exhibit 144: DiaSorin SpA - Overview
              • Exhibit 145: DiaSorin SpA - Business segments
              • Exhibit 146: DiaSorin SpA - Key news
              • Exhibit 147: DiaSorin SpA - Key offerings
              • Exhibit 148: DiaSorin SpA - Segment focus
            • 12.11 Enzo Biochem Inc.
              • Exhibit 149: Enzo Biochem Inc. - Overview
              • Exhibit 150: Enzo Biochem Inc. - Product / Service
              • Exhibit 151: Enzo Biochem Inc. - Key offerings
            • 12.12 Miltenyi Biotec B.V. and Co. KG
              • Exhibit 152: Miltenyi Biotec B.V. and Co. KG - Overview
              • Exhibit 153: Miltenyi Biotec B.V. and Co. KG - Product / Service
              • Exhibit 154: Miltenyi Biotec B.V. and Co. KG - Key news
              • Exhibit 155: Miltenyi Biotec B.V. and Co. KG - Key offerings
            • 12.13 Sartorius AG
              • Exhibit 156: Sartorius AG - Overview
              • Exhibit 157: Sartorius AG - Business segments
              • Exhibit 158: Sartorius AG - Key news
              • Exhibit 159: Sartorius AG - Key offerings
              • Exhibit 160: Sartorius AG - Segment focus
            • 12.14 Sony Group Corp.
              • Exhibit 161: Sony Group Corp. - Overview
              • Exhibit 162: Sony Group Corp. - Business segments
              • Exhibit 163: Sony Group Corp. - Key news
              • Exhibit 164: Sony Group Corp. - Key offerings
              • Exhibit 165: Sony Group Corp. - Segment focus
            • 12.15 Stratedigm Inc.
              • Exhibit 166: Stratedigm Inc. - Overview
              • Exhibit 167: Stratedigm Inc. - Product / Service
              • Exhibit 168: Stratedigm Inc. - Key offerings
            • 12.16 Sysmex Corp.
              • Exhibit 169: Sysmex Corp. - Overview
              • Exhibit 170: Sysmex Corp. - Business segments
              • Exhibit 171: Sysmex Corp. - Key offerings
              • Exhibit 172: Sysmex Corp. - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 173: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 174: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 175: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 176: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 177: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 178: Inclusions checklist
                • Exhibit 179: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 180: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 181: Research methodology
                • Exhibit 182: Validation techniques employed for market sizing
                • Exhibit 183: Information sources
              • 13.5 List of abbreviations
                • Exhibit 184: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              flow cytometry market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis